<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>1475-2875-7-112.fm</title>
<meta name="Author" content="abdulkadir.sufi"/>
<meta name="Creator" content="FrameMaker 8.0"/>
<meta name="Producer" content="Acrobat Distiller 8.1.0 (Windows)"/>
<meta name="CreationDate" content=""/>
</head>
<body>
<pre>
Malaria Journal

BioMed Central

Open Access

Research

Polymorphism patterns in Duffy-binding protein among Thai
Plasmodium vivax isolates
Panita Gosi1,2, Srisin Khusmith*1, Thareerat Khalambaheti1, David E Lanar3,
Kurt E Schaecher2, Mark M Fukuda2 and Scott R Miller3
Address: 1Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 10400,
Thailand, 2Department of Immunology and Medicine, Armed Forces Research Institute of Medical Science-United States Army
MilitaryComponent, Bangkok, Thailand and 3Walter Reed Army Institute forResearch, Washington, District of Columbia, USA
Email: Panita Gosi - panitag@afrims.org; Srisin Khusmith* - tmskm@mahidol.ac.th; Thareerat Khalambaheti - tmtkl@mahidol.ac.th;
David E Lanar - david.lanar@us.army.mil; Kurt E Schaecher - Kurt.Schaecher@afrims.org; Mark M Fukuda - Mark.Fukuda@afrims.org;
Scott R Miller - robert.s.miller@amedd.army.mil
* Corresponding author

Published: 26 June 2008
Malaria Journal 2008, 7:112

doi:10.1186/1475-2875-7-112

Received: 8 February 2008
Accepted: 26 June 2008

This article is available from: http://www.malariajournal.com/content/7/1/112
Â© 2008 Gosi et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract
Background: The Duffy-binding protein II of Plasmodium vivax (PvDBPII) has been considered as an
attractive target for vaccine-mediated immunity despite a possible highly polymorphic nature.
Among seven PvDBP domains, domain II has been shown to exhibit a high rate of nonsynonymous
polymorphism, which has been suggested to be a potential immune (antibody binding) evasion
mechanism. This study aimed to determine the extent of genetic polymorphisms and positive
natural selection at domain II of the PvDBP gene among a sampling of Thai P. vivax isolates.
Methods: The PvDBPII gene was PCR amplified and the patterns of polymorphisms were
characterized from 30 Thai P. vivax isolates using DNA cloning and sequencing. Phylogenetic
analysis of the sequences and positive selection were done using DnaSP ver 4.0 and MEGA ver 4.0
packages.
Results: This study demonstrated a high rate of nonsynonymous polymorphism. Using Sal I as the
reference strain, a total of 30 point-mutations were observed in the PvDBPII gene among the set of
Thai P. vivax isolates, of which 25 nonsynonymous and five synonymous were found. The highest
frequency of polymorphism was found in five variant amino acids (residues D384G, R390H, L424I,
W437R, I503K) with the variant L424I having the highest frequency. The difference between the
rates of nonsynonymous and synonymous mutations estimated by the Nei and Gojobori's method
suggested that PvDBPII antigen appears to be under selective pressure. Phylogenetic analysis of
PvDBPII Thai P. vivax isolates to others found internationally demonstrated six distinct allele groups.
Allele groups 4 and 6 were unique to Thailand.
Conclusion: Polymorphisms within PvDBPII indicated that Thai vivax malaria parasites are
genetically diverse. Phylogenetic analysis of DNA sequences using the Neighbour-Joining method
demonstrated that Thai isolates shared distinct alleles with P. vivax isolates from different
geographical areas. The study reported here will be valuable for the development of PvDBPII-based
malaria vaccine.

Page 1 of 8
(page number not for citation purposes)

Malaria Journal 2008, 7:112

Background
Molecular mechanisms of invasion by Plasmodium vivax
merozoites are mediated by the Duffy-binding-like (DBL)
family of homologous erythrocyte binding protein (EBPs)
located within the micronemes of merozoites that recognize specific receptors on red blood cell [1]. PvDBP is a
140-kDa protein belonging to a family of erythrocyte
binding proteins characterized by a functionally conserved cysteine-rich region. The similarity among DBL
families of EBPs is the greatest within two adjacent
cysteine-rich domains, designated as the amino cysteinerich domain (N-cys) and carboxyl cysteine-rich domain
(C-cys) [2]. The amino cysteine-rich domain has been
identified as the principle adhesion region binding to
erythrocyte receptors, while the function of the carboxyl
cysteine-rich domain remains unclear. This aminocysteine-rich domain is present within the 330 amino acid
region II, which has been shown to contain the binding
motifs necessary for adherence to the Duffy antigen receptor for chemokines (DARC), required for erythrocyte invasion [3]. Critical binding motifs in PvDBPII have been
mapped to a 170 amino acid spanning region between
cysteines 4 and 7 (amino acids 291â€“460) [4]. Cysteine
residues are conserved within the identified binding
motif, whereas other amino acids are highly polymorphic,
having a high ratio of nonsynonymous to synonymous
mutations [5].
The polymorphic nature of the PvDBP, particularly its
region II (DBPII) is a major impediment to the development of a broadly protective vaccine against vivax malaria.
A study in Papua New Guinea showed 43 and 18 unique
nonsynonymous mutations in 10 Madang [6] and 24
Wosera vivax isolates [7], respectively, whereas 19 unique
nonsynonymous mutations were described in 10 Colombian vivax isolates [8]. Often the mutations were found in
corresponding locations in the protein sequence of isolates from different geographical areas. Amino acids substitutions at D384G, K386(N/Q), N417K, L424I, W437R,
and I503K were found in both Papua New Guinea isolates
and Colombia isolates [5-8]. Such results demonstrate
that many similar alleles are widely distributed among P.
vivax from different geographical areas. Polymorphic patterns in the PvDBP cluster within the critical erythrocytebinding segment imply the existence of a selection pressure on PvDBP [9]. Under the influence of immune pressure, the distribution of existing antigenic polymorphisms
affects the population structure in which newly selected
mutants spread and may provide insight to the evolution
and selection of parasite populations over time [10]. Polymorphisms of PvDBPII require further exploration
among vivax isolates from different geographic areas, particularly south-east Asia where a large proportion of vivax
infections take place. Therefore, the gene polymorphisms

http://www.malariajournal.com/content/7/1/112

within the region II domain of the P. vivax DBP among
Thai P. vivax isolates were investigated.

Methods
P. vivax samples and DNA preparation
Plasmodium vivax isolates were obtained from malaria
patients with informed consent at the outpatient clinic,
Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, from May, 2002 to
June, 2003 under a protocol approval by the Ethics Committee, Faculty of Tropical Medicine, Mahidol University.
The confirmation of P. vivax infection was done by microscopic examination of the parasites in thick and thin
blood smears. Approximately 1 ml of venous blood was
collected from each individual in 0.5 M ethylene-diamine
tetra-acetic acid (EDTA) tubes and kept at -20Â°C until use.
Genomic DNA was extracted from 200 Î¼l of blood using
a High Pure PCR Template Preparation Kit (Roche, Mannhein, Germany) according to the manufacturer's protocol.
Genotyping of P. vivax isolates at the PvDBPII locus
P. vivax DBPII gene was amplified by PCR using the oligonucleotide primers, DBPII-F; 5'-CACCACGATCTCTAGTGCTATTATA-3' and DBPII-R; 5'-TGTCACAACTTCCTGAG
TATT-3' [11]. PCR cycling conditions were 94Â°C for 3
min, 55Â°C for 1 min, and 72Â°C for 1 min for 35 cycles followed by a 10 min extension at 72Â°C. PCR products were
stained with 0.1 Î¼g/ml ethidium bromide and visualized
by digital photography under ultraviolet light. The PCR
products were run adjacently to 0.1 Î¼g/lane of a 2-log
DNA ladder (NewEngland BioLabs, Inc. MA, USA) as a
standard DNA marker.
Purification of PCR products, DNA cloning and DNA
sequencing of PvDBPII gene
PCR products were purified by QIAquick PCR purification
Kit (Qiagen Inc., Valencia, CA) following the manufacturer's instructions. The PCR products were cloned
directly into pCR-Blunt II-TOPO cloning vector using a
Zero Blunt TOPO PCR cloning kit (Invitrogen, La Jolla,
CA). For DNA sequencing of the species-specific amplicons, excess dNTPs and unincorporated primers were
eliminated using the QIAquick PCR purification kit (Qiagen Inc., Valencia, CA). DNA sequencing was performed
by fluorescence based methodologies using MegaBACE
DNA Analysis Systems (Amersham Biosciences, Piscataway, NJ). The sequences have been submitted to the GenBank under the accession number EF219451, EF368159â€“
368180, EF379127â€“379135. Due to the possibility of
multiple genotypes within parasites taken from one individual, direct sequencing was not performed. Instead, at
least five clones were sequenced from each corresponding
PCR product and sequences of these had to be identical to
meet our quality control standards.

Page 2 of 8
(page number not for citation purposes)

Malaria Journal 2008, 7:112

http://www.malariajournal.com/content/7/1/112

Analysis of PvDBPII gene sequences
The alignment of complete sequences of 30 PvDBPII genes
was analysed by Sequencher ver 4.2 software (Gene Code
Corporation, Ann Arbor, MI) [12,13]. Sequences were
aligned using CLUSTALX Multiple Sequence Alignment
Program developed by the National Center for Biotechnology Information (NCBI, Bethesda, MD). The percent
similarity was assessed using BLASTN (NCBI, Bethesda,
MD) and BioEdit ver 7.0 software (Tom Hall Isis Therapeutics, Isis Pharmaceuticals, CA), DnaSP ver 4.0 [14] and
MEGA ver 4.0 Beta program [15].
Analysis of natural selection
Evidence of positive natural selection was determined by
comparing the rate of nonsynonymous and synonymous
substitutions in region II of the P. vivax DBP gene. The
rates of substitutions were estimated using the Nei and
Gojobori's method [16] with the Jukes and Cantor correction [17,18] as implemented in the MEGA program.
Standard error was determined by 1000 bootstrap replications. Negative selection acting on most coding genes can
be identified typically when the rate on nonsynonymous
mutations is less than the rate of synonymous mutations
(kn <Ks). However, when positive selection is acting on a
gene, the rate of nonsynonymous mutations will exceed
that of synonymous mutations (kn > Ks). Two other tests
of neutrality were performed by Tajima's D test, Fu and
Li's D- and F-tests on DnaSP 4 software using P. knowlesi
DBP as an outgroup. Tajima's D test compares the estimation of nucleotide diversity calculated in two ways (Î¸ calculated from the number of segregating sites and Ï€
calculated from average pairwise nucleotide diversity) in
order to test for a departure from neutrality. Fu and Li's D
and F test, departures from neutrality are identified as a
deviation between estimates of Î¸ (derived from the
number of mutations in external branches of the phylogeny and from the total number of mutations giving the
index D or from the average pairwise diversity Ï€ giving the
index F) [19].
Phylogenetic analysis
Phylogenetic analysis was used to investigate the associations of PvDBPII gene with sequences elucidated from dif-

ferent geographical regions. The gene tree was constructed
using regions common to all available PvDBPII
sequences. Forty five PvDBPII genes sequences found in
GenBank were compiled and compared to Thai isolates
including the sequences from a reference strain, Sal I, one
individual sequence from Vietnam, Indonesia, Brazil and
India as well as 2, 3, 3 and 31 sequences from Bangladesh,
Colombia (COL), South Korea (SK) and Papua New
Guinea (PNG), respectively (Table 1). A phylogenetic tree
was derived from the aligned nucleotide sequences using
the Neighbour-Joining (NJ) method with 1000 bootstrap
replicates, the Tamura's three-parameter distance model
as implemented in the MEGA ver 4.0 Beta program [20].

Results
PCR products and genetic polymorphisms of PvDBPII
gene among Thai isolates
The PCR amplification of the P. vivax DBPII gene from 30
Thai isolates yielded DNA fragments of approximately
990 base pairs in length (Figure 1). A 900 bp was selected
after excluding primer regions and adjacent bases which
did not give uniformly reliable sequences. DNA analysis
in comparison to the PvDBP gene of Sal I reference strain
revealed amino acid polymorphisms across the entire
domain II of PvDBP protein (300 amino acids) among
Thai isolates. Among the 30 polymorphic sites, 29
showed monomorphic mutation (changed into one
amino acid-type) and only a position 386(N/Q) showed
dimorphic mutation (changed into two amino acidtypes) (Table 2). Among 300 amino acids within PvDBPII,
25 nonsynonymous (representing 83% of all isolates) and
five synonymous mutations were identified (Table 2).
High frequencies of variant amino acids (>50%) were
found and included L424I (86%), D384G (76%), W437R
(63%), R390H (56%), and I503K (56%) residue polymorphisms.

Based on the variation of nonsynonymous mutations and
in comparison to Sal I the Thai haplotyes were designated
as TA (TA1-TA25). TA1, TA5 and TA11 haplotypes were
identified in two isolates while TA17 was identified in
three isolates. The other 21 haplotypes were identified in
single isolates (Table 3). The cluster analysis of PvDBPII

Table 1: PvDBPII sequences deposited in GenBank used in the study

species

locality

P. vivax
P. vivax
P. vivax
P. vivax
P. vivax
P. vivax
P. vivax
P. vivax

Papua New Guinea
Colombia
Korea
India
Brazil
Vietnam
Indonesia
Sal I

GenBank accession number
AF289480â€“289653, AF469522â€“469602, AY970848â€“970925, AF291096, AF695565, DQ156519
AY341907, DQ156513, AY341899
AF215737, AF215738, DQ156523
DQ156514
DQ153520
DQ156518
DQ156521
M37514, DQ156512

Page 3 of 8
(page number not for citation purposes)

Malaria Journal 2008, 7:112

http://www.malariajournal.com/content/7/1/112

Table 2: Amino acid changes found in PvDBPII gene among 30 Thai isolates, comparing to DBP Sal I sequence.
ÐŒ

Position of the amino acid

SalI
Thai
SalI
Thai
a
b

268
CGT
AGT
R
S
(1/30)
3

276
AAC
AAT
N
N
(1/30)
3

281
GTT
GTA
V
V
(1/30)
3

306
TTT
TTG
F
L
(2/30)
6

308
AGG
AGT
R
S
(8/30)
26

333
CTT
TTT
L
F
(14/30)
46

351
AGT
TGT
S
C
(1/30)
3

367
ATC
ACC
I
T
(2/30)
6

371
AAA
GAA
K
E
(6/30)
20

375
AAT
GAT
N
D
(7/30)
23

378
CGC
CGT
R
R
(30/30)
100

384
GAT
GGT
D
G
(23/30)
76

385
GAA
AAA
E
K
(14/30)
46

386
AAG
AAT/CAG
K
N/Q
(13/30)
43

390
CGT
CAT
R
H
(17/30)
56

419
ATA
ATG
I
M
(1/30)
3

424
TTA
ATA
L
I
(26/30)
86

433
CAG
AAG
Q
K
(1/30)
3

436
AGA
ACA
R
T
(1/30)
3

437
TGG
CGG
W
R
(19/30)
63

447
TCA
TCC
S
S
(1/30)
3

464
ATC
ATA
I
I
(1/30)
3

475
CCA
GCA
P
A
(3/30)
10

486
CAA
GAA
Q
E
(2/30)
6

503
ATA
AAA
I
K
(17/30)
56

507
AAC
CAC
N
H
(1/30)
3

513
ACG
AAG
T
K
(1/30)
3

Position of the amino acid

Sal I
Thai
Sal I
Thai
a
b

398
TCT
ACT
S
T
(3/30)
10

404
ACA
AGA
T
R
(3/30)
10

417
AAT
AAA
N
K
(11/30)
36

a Showing the detection frequency of each amino acids variant on PvDBPII protein among 30 Thai isolates.
b Percentage of detection frequency calculated from value in panel "a".
High prevalence (>50%) of variant amino acids.
ÐŒ Dimorphic mutation (changed into two amino acid-types)

amino acid sequences among 25 haplotypes based on
Neighbour-Joining method was organized into five main
groups (Figure 2).
Evidence of natural selection
To investigate whether natural selection contributed to
generation of this diversity, the ratio of nonsynonymous
(Kn) to synonymous substitutions (Ks) was compared
between Thai and Sal I isolates. The number of nonsynonymous substitutions per nonsynonymous sites (Kn)
(0.00956) exceeded the number of synonymous substitutions per synonymous sites (Ks) (0.00754). The Kn/Ks
ratio was 1.270 predicting that positive selection may be
occurring in region II of DBP favouring the fixation of
amino acid replacement in certain areas of the protein.
The statistic tests detecting departure from neutrality
showed evidence that the observed polymorphism might
be trending natural selection. Tajima's D value was 0.084549 with P > 0.10. The Fu and Li, D and F values

Signal

N-cys

C-cys

TM

Figure 1 diagram of PvDBPII gene showing the location of
the primers
Schematic
Schematic diagram of PvDBPII gene showing the location of
the primers.

were -0.92031 with P > 0.10 and -0.7654 with P > 0.10,
respectively.
Phylogenetic tree of PvDBPII
Phylogenetic tree analysis of DNA sequences derived from
region II of the P. vivax DBP constructs based on the
Neighbour-Joining method using Tamura's three-parameter distance is shown in Figure 3. Variation of DNA
sequence was categorized into nine distinct alleles groups.
Thai isolates were widely distributed amongst groups 1, 3,
5 and 7 also containing isolates from different geographical regions. PvDBPII DNA sequence of Thai isolates was
related to isolates sets from Papua New Guinea and India
(group 1), Korea (group 3), Colombia (group 5) and a
second Papua New Guinea set (group 7). The Sal I reference strain used in this study was included in group 2
composed of isolates from Colombia, Korea, Bangladesh,
Indonesia, and Vietnam, but bootstrap analysis demonstrated that the Thai isolates were distinct from this group.
Most isolates from Papua New Guinea formed a distinctive group comprised of 8 and 9.

Discussion
The process invasion into erythrocyte is essential for survival of P. vivax parasite and requires DBP to bind the
Duffy blood group antigen that act as erythrocyte receptor, Duffy antigen receptor for chemokines (DARC). Plasmodium vivax utilizes genetic diversity of individual
functional proteins to evade the host immune system and
resist many anti-malarial drugs [21]. In this study, polymorphisms and natural selection was assessed and suggested positive natural selection in PvDBPII of Thai
isolates. Although, non significant could be observed
trending positive selection. As this is only a glimpse at the

Page 4 of 8
(page number not for citation purposes)

Malaria Journal 2008, 7:112

http://www.malariajournal.com/content/7/1/112

Table 3: PvDBPII haplotypes observed among 30 Thai isolates.
Haplotype name

Amino acid haplotype*

No. of isolate observed (%)

TA 1
TA 2
TA3
TA 4
TA 5
TA6
TA 7
TA 8
TA 9
TA 10
TA 11
TA 12
TA 13
TA 14
TA 15
TA 16
TA 17
TA 18
TA19
TA 20
TA 21
TA 22
TA23
TA 24
TA 25

RFRFSIKDGKNHSTKIIQRRPQKNT
RFSFSIKDGKNHSTKIIQRRPQKNT
RFSFSIKDGKKHSTKIIQRRPQKNT
RFRLSIKDGKNHSTKIIQRRPQKNT
RFRFSIENGKNRSTNIIQRRPQINT
RFRFSIENGKNRSTKIIQRRPQINT
RFSFSIKDGKNHSTNIIQRRPQINT
RFRLSIENGEKHSTKIIQRRPQKNT
RFRLSIENGEQRSTKIIQRRPQKNT
RFRLSIENGEKRSTKMIQRRPQINT
RLSLLSIKNGKNHTRNIIQRWPQINT
SFSLSIKNGKNHTRNIQRWPEINT
RFRLSTKNGEKHSTNIIQRWPQKHT
RFRLSTKNGEKHSTNIIQRWPQKHT
RFSLSIKNGEKRSTNIIQRWPQKNT
RFRLSIKNGEKRSTNIIQRWPQINT
RFRFSIKNDEKRSTNIIQRRAQKNT
RFRLSIKNDEKRSTNIIQRRPQKNT
RFRFSIKNDKKRSTNIIQRRPQKNT
RFRLSIKNDKKRSTKIIKTRPQINT
RFRLSIKNDKKRSTNIIQRWPQINT
RFSFSIKDGKNHSTNILQRRPQKNT
RFRLSIKNGEKHSTNILQRWPQKNK
RFRLCIKNGEKHSTNILQRWPEINT
RFRLSIKNGEKHSTNILQRWPQINT

2(6.6)
1(3.3)
1(3.3)
1(3.3)
2(6.6)
1(3.3)
1(3.3)
1(3.3)
1(3.3)
1(3.3)
2(6.6)
1(3.3)
1(3.3)
1(3.3)
1(3.3)
1(3.3)
3(10)
1(3.3)
1(3.3)
1(3.3)
1(3.3)
1(3.3)
1(3.3)
1(3.3)
1(3.3)

* Amino acid residues included in the haplotypes are as follows: 268, 306, 308, 333, 351, 367, 371, 375, 384, 385, 386, 390, 398, 404, 417, 419, 424, 433, 436, 437, 475, 486,
503, 507, 513.

7$

overall population, a wide range study including more
subjects from different areas of Thailand would give a
more detailed picture.

7$

*URXS 

*URXS 

7$




7 $ 

7$

7$


7$


7$

7$ 


7$

7$

Â¢

*URXS 


7$

7$


7$

7$

Â£


7$
Â¡



7$

7$
7$

Â 

7$









7 $

*URXS 

Â§

Â¤

Â¥

7$

7$

6DO,

*URXS 


7$

7$

Analysis of 300 amino acids of PvDBPII protein relative to
the Sal I reference strain, resulted in 25 nonsynonymous
mutations being found. In addition, 142 nonsynonymous
mutations were reported in 76 Papua New Guinea isolates
[22]. The nonsynonymous mutations in PvDBPII might
have an effect on parasite binding to erythrocyte receptors.
Nonsynonymous mutations often times result in amino
acid substitutions that alter charge and therefore host
immune/antibody recognition [6]. Thus, excessive stable
polymorphism generation within the PvDBPII ligand
domain from high rate of nonsynonymous polymorphisms may promote the parasite escape of host immune
response [9].

Â¤

Figure observed tree of PvDBPII amino
variants 2
Neighbour-Joining among 30 Thai isolatesacid sequence of 25
Neighbour-Joining tree of PvDBPII amino acid sequence of 25
variants observed among 30 Thai isolates. The PvDBPII haplotype for each variant could be seen in Table 3.

The high frequency (>50%) of L424I (86%), D384G
(76%), W437R (63%), R390H (56%), and I503K (56%)
residues were found in Thai isolates relative to Sal I PvDBP
sequence. The finding is in contrast to previous studies
showing R308S (67%), D384G (66%), and S447K (59%)
in Papua New Guinea, D384G (59%) in Colombia and
D384G (85%) in Brazil isolates [23]. Of the following variants N417K, W437R and I503K, all having been shown
to be involved in evasion to antibody neutralization, variant N417K was found in low frequency (36%) while
W437R and I503K were high (63% and 56% respectively)
in Thai isolates. These results were different from what has
been currently reported in that the low frequencies of variants N417K (27.5%) and W437R (27.5%) and the high

Page 5 of 8
(page number not for citation purposes)

(page number not for citation purposes)

Page 6 of 8

areas, i.e. PNG (Papua New obtaining from Thai (Colombia), Korea, Bangladesh, from Indonesia, Vietnam, and Sal I
Phylogenetic tree of PvDBPII Guinea), India, COL P. vivax isolates and other isolatesBrazil, different geographical malaria endemic
Figure 3
Phylogenetic tree of PvDBPII obtaining from Thai P. vivax isolates and other isolates from different geographical malaria endemic
areas, i.e. PNG (Papua New Guinea), India, COL (Colombia), Korea, Bangladesh, Brazil, Indonesia, Vietnam, and Sal I. Numbers
at nodes indicate percentage support of 1000 bootstrap replicates (bootstrap support values below 10 are not presented).


Â¨



Â¨

"



















































8









8











8



8

8

Â©

Â©





"



!

Â©

8

Â©

Â©

G

G



"

Â¦

!

"

G

Â©

G

G

!

!

"

Â¦



"

"

!

G

!

!

!

!

Â¦



Â©

"

!

!

!

!

!

8

Â©



Â©

"



8

8

!

!

Â©





"

Â©

"

Â¨





8

Â¨

G

!

"

Â©

Â¦

*URXS 












f

f



Â¦

!

!

G

Â©

8







!

!

G

Â©

8







!

G

Â©

8



d



f

!





a



b



8





Â¦

!





!

Â¦

8



G



Â©

G

8



8



















Y

Â¦

8

Â¦

G

8

!

!





G



Â©



8





d

Y









U

Â©

!

!

G

Â©

8







a



`

Y

`
8

!

!

G

Â©

8







!

!

G

Â©

8







G

8











Y


V

G

8



"



"



!









G

!



Â¦



Â¥



Â£

Â¥

Â¡

Â£

Â 

Â¡

Â¥

b

d

Â 

Â£

8

Â¦

Â¡

Â¥

Â 

Â£

!

V

Â¡

6

Â 

4

Y

X

3

a

Â¡

Â 

`

Â¡

d

d

Â 

V
f

Â£

Â¡

Â 

Â¡

Â 

U
b

Â¡

Â 

Â¡

Â 

Â£

Â¡

Â 

Â¡

Â 
`

W

U

Â¥

Â£

Â¡

Y

Â 

d

Â¥

`





G

"

Â£

Â£

Â¥

Â£

Â£

Â£

Â¥

Â£

8

Â£

Â¡

`

Â 

Â£

Â¡

Â 

Â£

Y

Â¡

Â 

d

b

Â£

Â¡

Y

Â 

V

Â£

Â¡

Â¥

a



`

8

8

!



Â¥

Â¥

8

Â¥

Â¥

Â¥

"

Â¥

8

Â¨

Â¥

Â¥

Â¥

Â¥

Â©

V

Â 

Â£

Â¡

Â¥

Â 

Â£

Â¡

Â¥

a

Â 

Â£

Â¡

Â 

X

Â¥

Â£

Â¡

Â£

Â¡

G

Â©

Â©

!

G

G

8

G







8

!

"

Â¡

Â¥

T

Â£

"

!

Â¦

P

V

f

Â¡

S

T

!

2

Â 

R

S

!



"

Â¨

Â¦



!

!

2



(
E

"


A

Â¦

!

I

)
4

(

H

6



2



G



"

G

!

"

F

!

E

F

)
A

2

)

E





2



6

`

B



6

2

A

`

(

@

a

!

!

`

B

2

X

B

U
Y

W

!



"

Â¦

!

2
A

@





!

Â¦

4

6

4

6



!

Â¦

U

3

f



"

Â¦

!



2

Â¦

(

)

"

!







f

a

(





Y

3

`



!

Â©

"









b

"

!

"

Â©









Â¦

Â©



"





"











Y



X

!





`



d



Â¨

Â¥

a





Â¦

"

a

9
4

X

8

8



"

"

"

"

"

"

a

W

E

E

(
A

`

9

Â£

2
6

Â 

a

9

R

Q

(



`

Â 

Â£

Â£





Â¦

W

Â 

a

Â©

a



W

Â 

W

Â¥

Â£

`

8

8

W





G

G



Â¦

Â¦

Â©

Â¨

"

!

Â©

"

Â£

Â¡

Y

Â 

Â£

Â¡

a

Â 

Â¡

Â 

`

Â¥

Â£

Â¡

Y

Â 

V

U

X

Â¥

Y

d

d



d



Â¦

Â¦

"

Â©

"

Y

Â©

"

Â¨

Â©

Â©

Â©



Â¦



!

Â©

"

Â©

Â¦

Â¨

Â©

"



!

Â¥

"

b





(

Â¨

X

"

X





"

!

8

!



Â©





Â¨

Â¥



Â£

Â¦

Â¦

d







`
"

G

8

Â¦

Â¨

Â©

8

G

Â©

"

8

Â¨

Â©

Â¦

"



Â¦

!



!

Â©

Â¨



f

G

!

Â¨

!

!



"



Â¦

Â¨



Â¦

`

Â¨

Â¨

Â¨

"

!



Â©

Â©

Â¨

`





b

Â¥

Â¨

Â©

Â¦

a

`

`

Â¦



a



d

"



Â¦

8

*URXS 
*URXS 
*URXS 
*URXS 
*URXS 
*URXS 
*URXS 
*URXS 

Â£

Â¡

W

Â 

Malaria Journal 2008, 7:112

http://www.malariajournal.com/content/7/1/112

Malaria Journal 2008, 7:112

http://www.malariajournal.com/content/7/1/112

frequency of variant I503K (55%) found in Brazil and low
frequencies of all three variants (N417K, W437R, I503K)
found in either Colombia (47%, 18%, 12%, respectively)
and/or Papua New Guinea (23%, 26%, 29%, respectively)
(Table 4) [23]. N417K, W437R and I503K have recently
been shown to not be directly involved in erythrocyte
binding, but possibly in inhibition of antibody binding to
erythrocyte receptor [24]. Moreover, the variant amino
acid T404R was identified in PvDBPII domains of three
Thai isolates (Table 2) which is similar to the recent data
in Papua New Guinea [22]. Other Thai variants, namely
R308S, K371E, D384G, E385K, N386(N/Q), R390H,
T404R, N417K, L424I, W437R, S447S and I503K, were
also found in isolates of other regions, demonstrating
commonality with a progenitor clone (Table 4). The other
18 polymorphic residues of PvDBPII ligand domain were
recognized only among Thai isolates, indicative of divergence from a progenitor clone.
The study showed that 25 PvDBPII haplotypes clustered
into five main groups (dominant haplotypes) (Table 3)
on the basis of nonsynonymous mutations is similar, but
not entirely the same, with data from Papua New Guinea
isolates whose 27 different PvDBPII haplotypes clustering
into three dominant PvDBPII haplotypes. Potentially
dominant PvDBPII haplotypes observed in these populations could be less immunogenic, thereby may help promoting parasite success and escaping the host immune
response [22].
Phylogenetic analysis of PvDBPII suggested that Thai isolates fell into 6 different alleles groups. Among these,
group 1 formed a group with a subset of Papua New
Guinea isolates. Groups 4 and 6 were unique among Thai
P. vivax isolates. However, the rest of the allele groups that
Thai isolates fell into were more related to the isolates
from Korea, India, and Colombia than from Papua New
Guinea (Figure 3). The observations derived from the
PvDBPII phylogeny suggested that single Indian isolate
found in group 1 appeared to share a common ancestor
close to a subset of Thai and Papua New Guinea isolates,
demonstrating common ancestoral origins. Thai and
Papua New Guinea isolate subsets in group 7 also may
have shared common ancestor heritage. Recently, it was

reported that travellers' malaria among foreigners at the
Hospital for Tropical Diseases, Bangkok, Thailand including India and Papua New Guinea patients were though to
have acquired their infections in their countries. Malaria
importations from country to country can occur by either
immigration or travel, and changing malaria attack rates
in the countries of exposure are likely to influence the
incidence of imported disease [25]. Additionally, these
results demonstrated that there is some difference in the
nucleotide or amino acid variation in PvDBPII among isolates from Thai, Korea, India, Papua New Guinea and
Colombia, but most importantly, unique variants from
Thailand do exist and should be considered in future vaccine development of PvDBPII. It should be noted that the
present highly diverse phylogenetic tree was constructed
relying on polymorphisms within a single gene, demonstrating the high degree of topological variation that can
be found using this technique, but also highlighting the
problems that can be associated with gene sampling in
phylogenetic studies [26]. Use of a combination of several
genes with different rates of evolutions has been suggested
as an efficient way to overcome this difficulty to prove the
existence of a unique tree relating these sequences [27].
Finally, it must also be pointed out that in many situations a single-gene phylogeny may be interesting in itself.
Awareness of the problems of orthology (genes in different species that derive from a common ancestor) assignment and tree reconstruction artifacts should be
considered.

Conclusion
The results indicated that PvDBPII gene among Thai isolates is genetically diverse. Nonsynonymous polymorphism in PvDBPII was the predominant result of which
variant L424I showed the highest frequency (86%). Five
dominant PvDBPII haplotypes could be clustered among
Thai isolates. The high frequency of polymorphisms and
the presence of distinct alleles within PvDBPII gene
among P. vivax from different geographical areas could
provide complication in malaria vaccine development,
but should be considered important parts of the development process.

Table 4: Frequencies of the most common variant amino acids in PvDBPII, comparing to Sal I sequence (accession number M37519)

#

R308S

D384G

K386N

K386Q

N417K

L424I

W437R

S447K

I503K

Thai
COL*
PNG*
Brazil*

26
0
67
12.5

76
59
66
85

40
23
8
12.5

3
0
11
0

36
47
23
27.5

86
47
34
32.5

63
18
26
27.5

0
0
59
0

56
12
29
55

* The frequencies of the common variant amino acid data were referable according to Sousa et al. 2006.
# The first letter represented the amino acid in that position in Sal I sequences, and the other letter represents the substituted amino acid.
COL: Colombia, PNG: Papua New Guinea

Page 7 of 8
(page number not for citation purposes)

Malaria Journal 2008, 7:112

http://www.malariajournal.com/content/7/1/112

List of abbreviations used

12.

PvDBPII: Domain II of Plasmodium vivax DBP gene; DARC:
Duffy antigen receptor for chemokines

13.

Authors' contributions
SRM and SK designed the study, SK, MMF, SRM, KES, DEL
and TK, were responsible for the supervision of the work,
KES, TK, DEL, and PG were responsible for the sequences
and phylogenetic analysis, SK, MMF, SRM, KES, DEL, TK,
and PG drafted the manuscript. All authors read and
approved the final manuscript.

Acknowledgements
We thank the patients for their kind participation in this study; staff of the
Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University for their assistance in blood collection and COL Douglas S. Walsh,
US Army Medical Research Unit-Kenya for his valuable guidance and comments. This study was supported by the United States Army Medical
Research and Materiel Command, Fort Detrick, MD and Faculty of Tropical
Medicine, Mahidol University.

14.
15.
16.
17.
18.
19.
20.
21.

22.

Disclaimer
The views of the authors are solely there own, and do not reflect official
opinion of the United States Army Medical Research and Materiel Command or the Department of Defense.

23.

References

24.

1.
2.
3.

4.

5.

6.

7.

8.

9.
10.
11.

Adams JH, Sim BK, Dolan SA, Fang X, Kaslow DC, Miller : A family
of erythrocyte binding proteins of malaria parasites. Proc Natl
Acad Sci USA 1992, 89:7085-7089.
Fang XD, Kaslow DC, Adams JH, Miller LH: Cloning of the Plasmodium vivax duffy receptor. Mol Biochem Parasitol 1991, 44:125-132.
Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH: The
domain on the duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes.
J Exp Med 1996, 184:1531-1536.
Ranjan A, Chitnis CE: Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins. Proc Natl Acad
Sci USA 1999, 96:14067-14072.
Tsuboi T, Kappe SH, al-Yaman F, Prickett MD, Alpers M, Adams JH:
Natural variation within the principal adhesion domain of
the Plasmodium vivax duffy binding protein. Infect Immun 1994,
62:5581-5586.
Cole-Tobian JL, Cortes A, Baisor M, Kastens W, Xainli J, Bockarie M,
Adams JH, King CL: Age-acquired immunity to a Plasmodium
vivax invasion ligand, the duffy binding protein. J Infect Dis
2002, 186:531-539.
Xainli J, Adams JH, King CL: The erythrocyte binding motif of
Plasmodium vivax duffy binding protein is highly polymorphic
and functionally conserved in isolates from Papua New
Guinea. Mol Biochem Parasitol 2000, 111:253-260.
Ampudia E, Patarroyo MA, Patarroyo ME, Murillo LA: Genetic polymorphism of the duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol Biochem Parasitol
1996, 78:269-272.
Cole-tobian JL, King CL: Diversity and natural selection in Plasmodium vivax duffy binding protein gene. Mol Biochem Parasitol
2003, 127:121-132.
Rich SM, Hudson RR, Ayala FJ: Plasmodium falciparum antigenic
diversity: evidence of clonal population structure. Proc Natl
Acad Sci USA 1997, 94:13040-13045.
Dutta S, Daugherty JR, Ware LA, Lanar DE, Ockenhouse CF:
Expression, purification and characterization of a functional
region of the Plasmodium vivax duffy binding protein. Mol Biochem Parasitol 2000, 109:179-184.

25.

26.
27.

Tamura K: Estimation of the number of nucleotide substitutions when there are strong transition-transversion and
G+C-content biases. Mol Biol Evol 1992, 9:678-687.
Tajima F: Statistical method for testing the neutral mutation
hypothesis by DNA polymorphism. Genetics 1989, 123:585-595.
Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R: DnaSP, DNA
polymorphism analyses by the coalescent and other methods. Bioinformatics 2003, 19:2496-2497.
Kumar S, Tamura K, Nei M: MEGA3: Integrated software for
molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004, 5:150-163.
Nei M, Gojobori T: Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986, 3:418-426.
Jukes TH: The neutral theory of molecular evolution. Genetics
2000, 154:956-958.
Cantor CR, Fields CA: Genome sequencing conference. III:
Evolution and progress. Genomics 1992, 12:419-420.
Fu YX, Li WH: Statistical tests of neutrality of mutations.
Genetics 1993, 133:693-709.
Hillis DM: Phylogenetic analysis. Curr Biol 1997, 7:R129-131.
VanBuskirk KM, Cole-Tobian JL, Baisor M, Sevova ES, Bockarie M,
King CL, Adams JH: Antigenic drift in the ligand domain of Plasmodium vivax duffy binding protein confers resistance to
inhibitory antibodies. J Infect Dis 2004, 190:1556-1562.
Cole-Tobian JL, Michon P, Dobod E, Mueller I, King CL: Dynamics
of asymptomatic Plasmodium vivax infections and duffy binding protein polymorphisms in relation to parasitemia levels
in Papua New Guinean children. Am J Trop Med Hyg 2007,
77:955-962.
Sousa TN, Ceravolo IP, Fontes CJF, Couto A, Carvalho LH, Brito
CFA: The pattern of major polymorphisms in the duffy binding protein ligand domain among Plasmodium vivax isolates
from the Brazilian Amazon area. Mol Biochem Parasitol 2006,
146:251-254.
VanBuskirk KM, Sevova E, Adams JH: Conserved residues in the
Plasmodium vivax Duffy-binding protein ligand domain are
critical for erythrocyte receptor recognition. Proc Natl Acad Sci
USA 2004, 101:15754-15759.
Piyaphanee W, Krudsood S, Silachamroon U, Pornpininworakij K,
Danwiwatdecha P, Chamnachanan S, Wilairatana P, Looareesuwan S:
Travelers' malaria among foreigners at the Hospital for
Tropical Diseases, Bangkok, Thailand â€“ a 6-year review
(2000â€“2005). Korean J Parasitol 2006, 44:229-232.
Castresana J: Topological variation in single-gene phylogenetic
trees. Genome Biol 2007, 8:216.
Hypsa V: Parasite histories and novel phylogenetic tools:
alternative approaches to inferring parasite evolution from
molecular markers. Int J Parasitol 2006, 36:141-155.

Publish with Bio Med Central and every
scientist can read your work free of charge
"BioMed Central will be the most significant development for
disseminating the results of biomedical researc h in our lifetime."
Sir Paul Nurse, Cancer Research UK

Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours â€” you keep the copyright

BioMedcentral

Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp

Page 8 of 8
(page number not for citation purposes)

</pre>
</body>
</html>
